VIVEbiotech
PrivateLast Round
Growth Equity
Dec 4, 2024
Total Funding Raised
$3.85M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
VIVEbiotech operates in Healthcare & Life Sciences and is based in Spain. Its latest recorded funding round was a Growth Equity round in December 2024.
VIVEbiotech is a biotechnology company that operates as a Contract Development and Manufacturing Organization (CDMO) specializing in lentiviral vectors for the gene and cell therapy sectors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VIVEbiotech Comparables
Compare VIVEbiotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genezen | 90% | |
| ViroCell Biologics | 89% | |
| Vector BioMed, Inc. | 88% |
For institutional investors. Book with your work email.
VIVEbiotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Dec 4, 2024 | ||||
| VC Round | Jul 16, 2020 | ||||
| Seed | Sep 23, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
VIVEbiotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Inveready | VC Round, Seed |
| Easo Ventures | VC Round, Seed |
| Center for Technological Development and Innovation | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 297% MoM to 13.5K.
- Jul 25, 2026
Monthly visitors increased 163% MoM, reaching 3.4K.
For institutional investors. Book with your work email.
VIVEbiotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about VIVEbiotech's valuation, stock price, and market status.
Is VIVEbiotech a public or private company?
VIVEbiotech is a private company.
What is the current stock price of VIVEbiotech?
VIVEbiotech is a private company, so its shares have no public market price. Caplight tracks VIVEbiotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VIVEbiotech worth (valuation)?
Valuation information for VIVEbiotech is not publicly available.
Can I buy VIVEbiotech stock?
VIVEbiotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VIVEbiotech's last funding round?
VIVEbiotech's most recent funding round was Growth Equity on December 4, 2024.
Who are the main investors in VIVEbiotech?
Key investors in VIVEbiotech include Inveready, Easo Ventures.
Will VIVEbiotech IPO soon?
No public IPO plans have been announced for VIVEbiotech.
How can I track VIVEbiotech secondary market activity?
Caplight tracks bids, offers, and trades in VIVEbiotech's shares on secondary markets.